The coronavirus infection is an evolving pandemic with high morbidity and mortality, especially in people with comorbidities. The case fatality rate (CFR) is 9.2% in the presence of diabetes, while it is 1.4% in those without any comorbidity. Diabetes is a prevalent disease globally; hence, healthcare professionals are highly concerned about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic progression. Current evidence does not support higher incidence of coronavirus disease 2019 (COVID-19) in people with diabetes. However, people with diabetes are considered high risk for developing complications.
CEO of Chellaram Diabetes Institute, Pune
Dr AG Unnikrishnan is the CEO of Chellaram Diabetes Institute, a state-of-the-art diabetes hospital in Pune. He heads clinical care, research, education and also oversees a philanthropic rural diabetes care program at the Institute.
Filter out the noise and nurture your inbox with health and wellness advice that's inclusive and rooted in medical expertise.
Your privacy is important to us
MEDICAL AFFAIRS
CONTENT INTEGRITY
NEWSLETTERS
© 2022 Medtalks
